{"id":"https://openalex.org/W2321998134","doi":"https://doi.org/10.1097/ipc.0b013e31820a545d","title":"Snapshots From 2010 IDSA","display_name":"Snapshots From 2010 IDSA","alternate_titles":[],"publication_year":2011,"publication_date":"2011-03-01","ids":{"openalex":"https://openalex.org/W2321998134","doi":"https://doi.org/10.1097/ipc.0b013e31820a545d","mag":"2321998134"},"language":"en","primary_location":{"id":"doi:10.1097/ipc.0b013e31820a545d","doi":"https://doi.org/10.1097/ipc.0b013e31820a545d","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ipc.0b013e31820a545d","pdf_url":null,"source":{"id":"https://openalex.org/S172423242","display_name":"Infectious Diseases in Clinical Practice","issn_l":"1056-9103","issn":["1056-9103","1536-9943"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases in Clinical Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2321998134"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044884979","display_name":"Ted Louie","orcid":"https://orcid.org/0000-0001-7288-1116","observed_orcids":["https://orcid.org/0000-0001-7288-1116"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ted Louie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5044884979"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"2","first_page":"80","last_page":"82"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11000","display_name":"Infection Control in Healthcare","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.9580000042915344},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9440000057220459},{"id":"https://openalex.org/keywords/clostridium-difficile-associated-diarrhea","display_name":"Clostridium difficile-associated diarrhea","score":0.9589999914169312},{"id":"https://openalex.org/keywords/antibiotic-costs","display_name":"antibiotic costs","score":0.5609999895095825},{"id":"https://openalex.org/keywords/hospital-infection-control","display_name":"hospital infection control","score":0.515999972820282},{"id":"https://openalex.org/keywords/antimicrobial-use-surveillance","display_name":"antimicrobial use surveillance","score":0.4620000123977661},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility-testing","display_name":"antimicrobial susceptibility testing","score":0.45100000500679016},{"id":"https://openalex.org/keywords/antibiotic-prophylaxis","display_name":"antibiotic prophylaxis","score":0.5580000281333923},{"id":"https://openalex.org/keywords/antimicrobial-de-escalation","display_name":"antibiotic de-escalation","score":0.6129999756813049},{"id":"https://openalex.org/keywords/antibiotic-duration","display_name":"antibiotic duration","score":0.32100000977516174},{"id":"https://openalex.org/keywords/antimicrobial-toxicity","display_name":"antimicrobial toxicity","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9408680200576782}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/ipc.0b013e31820a545d","doi":"https://doi.org/10.1097/ipc.0b013e31820a545d","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ipc.0b013e31820a545d","pdf_url":null,"source":{"id":"https://openalex.org/S172423242","display_name":"Infectious Diseases in Clinical Practice","issn_l":"1056-9103","issn":["1056-9103","1536-9943"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases in Clinical Practice","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2333458986","https://openalex.org/W2041721194","https://openalex.org/W2074377198","https://openalex.org/W3040276670","https://openalex.org/W2101544940","https://openalex.org/W4210538332","https://openalex.org/W1983573791","https://openalex.org/W2226452988","https://openalex.org/W4294568877","https://openalex.org/W2134845753"],"abstract_inverted_index":{"It":[0,258,590,716,1769],"is":[1,327,678,717,768,839,1319,1539,1760,1777,1783],"an":[2,328,474,746,859,1224,1716],"impossible":[3],"task":[4],"to":[5,21,71,74,103,108,116,131,155,227,249,263,293,317,334,365,383,424,719,787,802,910,1073,1088,1151,1154,1161,1190,1202,1215,1371,1376,1559,1915],"assemble":[6],"a":[7,235,358,373,431,446,451,497,741,1083,1144,1179,1320,1344,1361,1606,1614,1653,1762,1771,1909],"summary":[8],"of":[9,24,81,90,94,99,120,159,163,176,212,281,314,323,340,378,445,496,521,576,599,608,620,642,676,693,699,737,766,777,951,979,1014,1056,1135,1178,1259,1322,1436,1457,1504,1537,1553,1617,1659,1671,1715,1736,1764,1774,1812,1865,1878,1894,1918,1926,1941,1982,1992],"IDSA,":[10,350],"but":[11,659,808],"I":[12,929],"have":[13,153,1067,1185,1210,1282,1288,1547],"chosen":[14],"major":[15,97],"themes":[16],"that":[17,170,594,727,1065,1086,1222,1249,1534,1646,1908],"should":[18,751,772,831,1184],"prove":[19],"useful":[20,789,1323,1370],"the":[22,33,78,85,118,147,157,174,210,213,216,219,243,256,261,264,278,286,295,299,304,348,354,366,380,597,606,618,663,682,708,781,815,837,846,852,863,947,992,1054,1099,1108,1123,1133,1173,1194,1228,1257,1279,1292,1295,1298,1364,1535,1551,1593,1657,1810,1830,1847,1863,1870,1879,1902,1975],"majority":[23],"clinicians.":[25],"The":[26,96,574,674,775,1043,1168,1892,1905],"slides":[27],"and":[28,35,61,76,92,111,115,139,143,215,254,271,357,396,468,530,584,615,626,630,649,669,712,759,895,949,1046,1079,1127,1157,1163,1234,1294,1325,1358,1387,1403,1500,1555,1597,1776,1802,1862,1867,1922,1939,1979,1986,1990],"audio":[29],"are":[30,102,635,644,653,671,810,842],"available":[31],"on":[32,206,298,361,662,704,845,881,905,1092,1114,1541,1869],"Internet":[34],"can":[36,172,182,200,223,728],"be":[37,386,730,752,773,788,800,832,866,1152,1275,1341,1369],"purchased":[38],"by":[39,83,284,344,876,1149,1172,1422],"logging":[40],"onto":[41,291],"www.siattend.com/IDSA.":[42],"PREMEETING":[43],"SESSION":[44,566,1027,1521,1755],"1.":[45,389,400,415,436,459,480,924,1379,1683,1837,1929],"IMPLEMENTING":[46],"ANTIMICROBIAL":[47,1523],"STEWARDSHIP":[48],"PROGRAMS:":[49],"A":[50,695,1631],"WORKSHOP":[51],"ON":[52],"DEVELOPMENT,":[53],"MAINTENANCE,":[54],"AND":[55,1034],"MEASURING":[56],"SUCCESS.":[57],"CO-ORGANIZED":[58],"With":[59,1310],"SHEA":[60,300],"CDC1-5":[62],"Per":[63],"Dr.":[64],"Sarah":[65],"Cosgrove,":[66],"\"Antibiotic":[67],"stewardship":[68,101,124,181,432,476],"(AS)":[69],"refers":[70],"processes":[72],"designed":[73],"measure":[75],"optimize":[77],"appropriate":[79,86],"use":[80,575],"antimicrobials":[82],"selecting":[84],"agent,":[87,711],"dose,":[88,1649],"duration":[89],"therapy":[91],"route":[93],"administration.":[95],"objectives":[98],"antimicrobial":[100,121,144,411,455,475],"achieve":[104,1790],"optimal":[105],"clinical":[106,531,1115,1284,1351,1458,1713],"outcomes,":[107,137],"minimize":[109,117],"toxicity":[110,138],"other":[112,140,1303],"adverse":[113,141,1844],"events,":[114,142],"development":[119],"resistance.":[122,186],"Antimicrobial":[123,392,540,1478,1498],"may":[125,799,865,908,1274,1673],"also":[126,183,1219,1266,1674,1899],"reduce":[127],"excessive":[128],"costs":[129],"attributable":[130],"inappropriate":[132],"or":[133,229,745,827,1200,1204,1418,1507],"unnecessary":[134],"therapy,":[135],"suboptimal":[136],"resistance.\"2":[145],"For":[146,187,273,1330],"last":[148,1100],"10":[149],"years,":[150],"much":[151],"data":[152,252,1097,1220,1248,1324,1339,1851],"accumulated":[154],"support":[156],"benefits":[158],"AS.":[160,311,346],"In":[161,1350,1794,1846],"terms":[162],"patient":[164,217,816],"safety,":[165],"it":[166,1061,1183,1530],"has":[167,306,587,591,783,1049,1062,1094,1104,1531,1770],"been":[168,785,1050,1095,1186,1211,1289,1532],"shown":[169,307,786],"AS":[171,195,199,237,283,296],"decrease":[173,184,202],"incidence":[175],"Clostridium":[177,1813,1947],"difficile-associated":[178,1814],"diarrhea.6":[179],"Antibiotic":[180],"antibiotic":[185,203,499,550,1375],"example,":[188,604,652],"Pseudomonas":[189,1386,1586,1664,1710],"strains":[190,1208],"became":[191],"more":[192,230,274,337,1825,1910],"susceptible":[193],"after":[194,1887,1980],"was":[196,1805,1818,1873,1898],"initiated.7":[197],"Finally,":[198],"significantly":[201,679],"costs.":[204],"Depending":[205],"many":[207,376],"factors":[208,724],"including":[209,628],"size":[211],"hospital":[214,248,265,342],"mix,":[218],"yearly":[220],"cost":[221,1599],"savings":[222,1600],"range":[224],"from":[225,991,1122,1198,1761],"$140,000":[226],"$300,0008,9":[228],"at":[231,558,890],"larger":[232],"institutions.":[233],"Implementing":[234],"new":[236,1345],"program":[238,374,501],"involves":[239],"careful":[240],"planning,":[241],"identifying":[242],"key":[244],"members":[245,339],"in":[246,310,363,780,790,856,896,981,1017,1245,1343,1666,1740,1799,1820,1843,1854,1901,1946,1950],"your":[247,425,470],"help":[250,1372],"with":[251,681,869,884,902,914,983,987,1020,1353,1363,1438,1462,1466,1592,1745,1827,1955],"gathering,":[253],"executing":[255],"plan.":[257],"requires":[259,817],"\"selling\"":[260],"idea":[262],"administration,":[266],"physicians,":[267],"infection":[268,701,887,1949,1985],"control":[269],"committee,":[270],"pharmacy.5":[272],"information,":[275],"please":[276],"see":[277],"IDSA/SHEA":[279],"guidelines":[280,1091],"implementing":[282],"using":[285,450],"link":[287],"http://www.journals.uchicago.edu/doi/pef/10.1086/510393.":[288],"Also,":[289],"log":[290],"http://www.shea-online.org/news/stewardship.cfm":[292],"view":[294],"page":[297],"Web":[301],"site.":[302],"Note:":[303],"CDC":[305],"increasing":[308],"interest":[309],"As":[312,370,1270,1529],"methods":[313],"reimbursement":[315],"change":[316],"reward":[318],"quality":[319],"rather":[320],"than":[321,1883],"number":[322],"services":[324],"provided,":[325],"there":[326,351,1318],"opportunity":[329],"for":[330,429,454,473,525,554,580,603,638,651,793,804,995,1052,1098,1196,1226,1230,1241,1291,1383,1399,1477,1497,1569,1579,1585,1605,1609,1628,1642,1663,1709,1809],"infectious":[331,555,688],"disease":[332,556,689],"physicians":[333],"become":[335,592,1063,1105],"even":[336],"valued":[338],"their":[341,640],"systems,":[343],"providing":[345],"At":[347],"2010":[349,1485],"were":[352,1111,1218,1590,1601,1824,1833,1839,1852,1889],"\"Meet":[353],"Professor\"":[355],"sessions":[356],"satellite":[359],"symposium":[360],"AS,":[362],"addition":[364],"above":[367],"premeeting":[368],"session.":[369],"developing":[371],"such":[372,732,820,899,1315,1333],"takes":[375],"hours":[377,1574,1581,1640],"preparation,":[379],"best":[381],"time":[382,1250,1542,1552],"start":[384],"would":[385,1209],"immediately.":[387],"REFERENCES":[388,923,1378,1682,1928],"Fishman":[390,538],"N.":[391,539],"management:":[393],"design,":[394],"implementation,":[395],"efficacy.":[397,1262,1561],"Premeeting":[398,413,434,457,478],"session":[399,414,435,458,479],"No.":[401,416,437,460,481,937,956,1391,1407,1426,1688,1697,1960],"1":[402,1203],"IDSA;":[403,418,439,462,483,939,958,1393,1409,1428,1690,1962],"2010.":[404,419,440,463,484,940,959,1394,1410,1429,1493,1691,1700,1963],"2.":[405,941,1395,1692,1964],"Cosgrove":[406],"S.":[407],"Driving":[408],"change:":[409],"why":[410],"stewardship?":[412],"2":[417,1795,1951],"3.":[420,960,1411,1701],"Ohl":[421],"C.":[422,1895,1919,1983],"Tailoring":[423],"reality:":[426],"effective":[427],"strategies":[428],"designing":[430],"program.":[433,477],"3":[438,1643],"4.":[441,965,1430,1725],"Septimus":[442],"E.":[443],"Components":[444],"practical":[447],"implementation":[448],"approach:":[449],"\"driver":[452],"diagram\"":[453],"stewardship.":[456,541],"4":[461,1199,1580],"5.":[464,1003,1447],"Small":[465],"R.":[466],"Developing":[467],"delivering":[469],"business":[471],"case":[472,858],"5":[482],"6.":[485,1473],"Carling":[486],"P,":[487],"Fung":[488],"T,":[489,1009,1703,1935,1966],"Killion":[490],"A,":[491],"et":[492,518,972,1010,1454,1563,1732,1936,1971],"al.":[493,519,973,1011,1455,1733,1937,1972],"Favorable":[494],"impact":[495],"multidisciplinary":[498],"management":[500],"conducted":[502],"during":[503,1652,1978],"7":[504],"years.":[505,1102],"Infect":[506,534,563],"Control":[507],"Hosp":[508],"Epidemiol.":[509],"2003;24:699-706.":[510],"7.":[511,1494],"White":[512],"AC,":[513],"Atmar":[514],"RL,":[515],"Wilson":[516],"J,":[517],"Effects":[520],"requiring":[522],"prior":[523],"authorization":[524],"selected":[526,897],"antimicrobials:":[527],"expenditures,":[528],"susceptibilities,":[529],"outcomes.":[532],"Clin":[533,562,1443,1721],"Dis.":[535,564,1001,1723],"1997;25:230.":[536],"8.":[537],"Am":[542],"J":[543,1024],"Med.":[544,1025],"2006;119:S53-S61.":[545],"9.":[546],"LaRocco":[547],"A.":[548],"Concurrent":[549],"review":[551],"programs-a":[552],"role":[553],"specialists":[557],"small":[559],"community":[560],"hospitals.":[561],"2003;37:74-83.":[565],"28":[567],"SYMPOSIUM:":[568],"INFECTIOUS":[569],"COMPLICATIONS":[570],"OF":[571,1527],"IMMUNOMODULATORY":[572],"AGENTS1,2":[573],"immunomodulatory":[577],"agents":[578],"(IAs)":[579],"inflammatory":[581],"conditions,":[582],"malignancies,":[583],"neurologic":[585],"conditions":[586],"increased":[588],"greatly.":[589],"apparent":[593,1064],"IA":[595,838,864],"increase":[596],"risk":[598,607,619,675,698,714,723,792,978],"certain":[600],"infections.":[601,1587],"Rituximab,":[602],"increases":[605,617],"hepatitis":[609,757,853,916],"B":[610,758,854,917],"reactivation,":[611],"progressive":[612,794],"multifocal":[613,795],"leukoencephalopathy,":[614],"possibly":[616],"Pneumocystis":[621],"jiroveci":[622],"pneumonia,":[623],"atypical":[624],"mycobacteria,":[625],"viruses":[627],"enterovirus":[629],"parvovirus":[631],"B19.3":[632],"Although":[633],"IAs":[634],"grouped":[636],"together":[637],"convenience,":[639],"mechanisms":[641],"action":[643],"quite":[645],"different.":[646,1891],"Etanercept,":[647],"infliximab,":[648],"adalimumab,":[650],"all":[654,1206],"tumor":[655],"necrosis":[656],"\u03b1":[657],"inhibitors,":[658],"etanercept":[660],"acts":[661],"soluble":[664],"p75":[665],"receptor,":[666],"whereas":[667],"infliximab":[668],"adalimumab":[670],"monoclonal":[672,683],"antibodies.":[673],"tuberculosis":[677,886,980],"higher":[680],"antibodies.4":[684],"Dr":[685,1141,1236,1300],"Kotton":[686,925],"discussed":[687],"consultation":[690,1362],"before":[691,836,862],"initiation":[692],"IA.":[694,847,882],"patient's":[696],"relative":[697],"opportunistic":[700],"will":[702,850,871,888,918,1340,1367,1789],"depend":[703],"his/her":[705],"underlying":[706],"condition,":[707],"specific":[709,977],"immunosuppressive":[710],"epidemiologic":[713,722],"factors.":[715],"mandatory":[718],"ask":[720],"about":[721],"(for":[725,1619],"diseases":[726],"later":[729],"reactivated,":[731],"as":[733,754,756,821,900,921,1076,1188,1213,1305,1307,1316,1334,1625,1767,1835],"strongyloidiasis,":[734],"histoplasmosis,":[735],"and,":[736,1787],"course,":[738],"tuberculosis).":[739],"Either":[740],"PPD":[742],"skin":[743],"test":[744],"interferon":[747],"\u03b3":[748],"release":[749],"assay":[750],"done,":[753],"well":[755,1306],"C":[760],"serologies.":[761],"If":[762,814],"no":[763,1327,1840],"convincing":[764],"history":[765],"varicella":[767,770,823],"obtained,":[769],"antibodies":[771],"obtained.":[774],"presence":[776,1177,1258],"JC":[778,1015],"virus":[779,1016],"blood":[782],"not":[784,811,1112,1129,1256,1890],"predicting":[791],"leukoencephalopathy.5":[796],"Urine":[797],"antigen":[798],"used":[801,1118,1125,1313],"screen":[803,930],"active":[805,915,1779],"histoplasma":[806],"infection,":[807],"serologies":[809],"considered":[812,1276],"helpful.":[813,867],"live":[818],"vaccines":[819],"MMR,":[822],"zoster,":[824],"yellow":[825],"fever,":[826],"oral":[828,1849],"typhoid,":[829],"these":[830],"given":[833],"several":[834],"weeks":[835],"initiated;":[840],"they":[841,1066],"contraindicated":[843],"while":[844,880],"Some":[848],"patients":[849,931,982,1018,1461,1744,1857],"require":[851,872,889],"immunization,":[855],"which":[857,1165,1374,1855],"accelerated":[860],"schedule":[861],"Patients":[868],"Strongyloides":[870],"treatment,":[873,879],"perhaps":[874],"followed":[875],"periodic":[877],"repeated":[878],"Those":[883,913,1603],"latent":[885],"least":[891],"9":[892],"months":[893],"isoniazid,":[894],"circumstances":[898],"those":[901],"extensive":[903],"fibrosis":[904],"chest":[906],"radiograph,":[907],"opt":[909],"treat":[911],"longer.":[912],"need":[919],"treatment":[920,1811,1888,1981],"well.":[922],"CN.":[926],"How":[927],"do":[928],"anticipating":[932],"biologic":[933,952],"agents?":[934],"Session":[935,954,1389,1405,1424,1686,1695,1958],"28.":[936,955],"104.":[938],"Winthrop,":[942],"KL.":[943],"Beyond":[944],"TNF":[945],"inhibition:":[946],"risks":[948],"rewards":[950],"therapies.":[953],"106a.":[957],"Gea-Banagloche.":[961],"Semin":[962],"Hematol.":[963],"2010;47:187-198.":[964],"Dixon":[966],"WG,":[967],"Hyrich":[968],"KL,":[969],"Watson":[970],"KD,":[971],"Extended":[974,1669],"report:":[975],"drug":[976,1608],"rheumatoid":[984],"arthritis":[985],"treated":[986,1019,1465],"anti-TNF":[988],"therapy;":[989],"results":[990],"British":[993],"Society":[994],"Rheumatology":[996],"Biologics":[997],"Register.":[998],"Ann":[999],"Rheum":[1000],"2010;69:522-528.":[1002],"Chen":[1004],"Y,":[1005],"Bord":[1006],"E,":[1007],"Tompkins":[1008],"Asymptomatic":[1012],"reactivation":[1013],"natalizumab.":[1021],"N":[1022],"Engl":[1023],"2009;361:1067-1074.":[1026],"61":[1028],"SYMPOSIUM.":[1029],"UPDATES":[1030],"FROM":[1031],"THE":[1032],"CLINICAL":[1033],"LABORATORY":[1035],"STANDARDS":[1036],"INSTITUTE:":[1037],"WHAT":[1038],"EVERY":[1039],"CLINICIAN":[1040],"SHOULD":[1041],"KNOW1-3":[1042],"US":[1044],"Food":[1045],"Drug":[1047],"Administration":[1048],"responsible":[1051],"defining":[1053],"breakpoints":[1055,1110,1195,1229,1281,1287],"antibiotics":[1057,1314],"against":[1058,1232,1297,1679,1780,1807],"bacteria,":[1059],"yet":[1060,1159],"neither":[1068],"sufficient":[1069],"resources":[1070],"nor":[1071],"flexibility":[1072],"revise":[1074],"them":[1075],"needed.":[1077],"Clinical":[1078,1588],"Laboratory":[1080],"Standards":[1081,1476],"Institute,":[1082],"voluntary":[1084],"organization":[1085],"strives":[1087],"develop":[1089],"consensus":[1090],"breakpoints,":[1093],"reviewing":[1096],"8":[1101,1583,1639],"Revision":[1103],"necessary":[1106],"because":[1107],"original":[1109],"based":[1113,1540],"outcomes":[1116,1589],"data,":[1117],"different":[1119],"pharmacokinetic":[1120],"indices":[1121],"standards":[1124],"today,":[1126],"did":[1128],"take":[1130],"into":[1131,1549],"account":[1132],"appearance":[1134],"extended":[1136,1594,1717],"spectrum":[1137,1773],"beta-lactamase":[1138],"(ESBL)":[1139],"gram-negatives.2,3":[1140],"Schreckenberger1":[1142],"described":[1143],"Klebsiella":[1145],"pneumoniae":[1146],"strain":[1147,1169],"found":[1148],"Vitek":[1150],"sensitive":[1153],"cefepime,":[1155],"imipenem,":[1156],"gentamicin":[1158],"resistant":[1160,1189,1214,1354],"ertapenem":[1162],"tobramycin,":[1164],"seemed":[1166],"inconsistent.":[1167],"tested":[1170],"positive":[1171],"Hodge":[1174],"test,":[1175],"indicating":[1176],"carbapenemase":[1180],"(KPC),":[1181],"so":[1182],"reported":[1187,1212],"imipenem.":[1191,1216],"By":[1192],"adjusting":[1193],"imipenem":[1197],"less":[1201,1311,1877,1916,1924],"less,":[1205],"KPC":[1207],"There":[1217,1782,1823,1838],"presented":[1221,1853],"made":[1223],"argument":[1225],"lowering":[1227],"pipericillin-tazobactam":[1231,1618],"Enterobacteriaceae":[1233,1402,1464],"Pseudomonas.":[1235],"Ambrose4":[1237],"reviewed":[1238,1302],"break":[1239],"points":[1240],"cephalosporins.":[1242,1404],"He":[1243],"noted":[1244],"animal":[1246],"model":[1247],"over":[1251,1543],"minimum":[1252],"inhibitory":[1253],"concentration":[1254],"(MIC),":[1255],"ESBL,":[1260],"predicts":[1261],"Patient":[1263],"outcome":[1264,1459],"trials":[1265,1798,1954],"supported":[1267],"this":[1268,1647],"concept.5":[1269],"such,":[1271],"ESBL":[1272],"testing":[1273],"optional,":[1277],"provided":[1278,1342],"MIC":[1280],"true":[1283],"correlation.":[1285],"These":[1286],"revised":[1290],"carbapenems":[1293,1672],"cephalosporins":[1296],"Enterobacteriaceae.6":[1299],"Weinstein3":[1301],"agents,":[1304,1360],"unusual":[1308,1331,1356],"organisms.":[1309],"commonly":[1312],"colistin,":[1317],"paucity":[1321],"often":[1326,1368],"defined":[1328],"breakpoint.":[1329],"bacteria":[1332],"nutritionally":[1335],"variant":[1336],"Streptococcus,":[1337],"breakpoint":[1338],"document":[1346,1513],"starting":[1347],"January":[1348],"2011.7":[1349],"situations":[1352],"gram-negatives,":[1355],"organisms,":[1357],"novel":[1359],"microbiology":[1365],"director":[1366],"decide":[1373],"choose.":[1377],"Schreckenberger":[1380],"P.":[1381],"Rationale":[1382,1398],"changing":[1384,1400],"breakpoints:":[1385,1401,1420],"carbapenems.":[1388],"61.":[1390,1406,1425],"186.":[1392],"Ambrose":[1396,1452],"PG.":[1397],"187.":[1408],"Weinstein":[1412],"M.":[1413],"Bad":[1414],"bugs":[1415],"without":[1416],"CLSI":[1417],"FDA":[1419],"reasoning":[1421],"analogy?":[1423],"188.":[1427],"Craig":[1431,1448,1684],"WA,":[1432,1449],"Andes":[1433],"DR.":[1434],"Treatment":[1435],"infections":[1437],"ESBL-producing":[1439,1463],"organisms:":[1440],"pharmacokinetic-pharmacodynamic":[1441],"considerations.":[1442],"Microbiol":[1444],"Infect.":[1445],"2005;11:10-17.":[1446],"Bhavnani":[1450],"SM,":[1451],"PG,":[1453],"Evaluation":[1456],"among":[1460],"cephalosporin":[1467],"mono-therapy.":[1468],"ICAAC":[1469],"2005,":[1470],"Abstract":[1471],"K-1291.":[1472],"CSLI.":[1474,1495],"Performance":[1475],"Susceptibility":[1479,1502],"Testing:":[1480],"Twentieth":[1481],"Informational":[1482],"Supplement":[1483],"(June":[1484],"Supplement).":[1486],"CSLI":[1487,1512],"Document":[1488],"M100-S20-U.":[1489],"Wayne,":[1490,1517],"PA:":[1491,1518],"CSLI;":[1492,1519],"Methods":[1496],"Dilution":[1499],"Disk":[1501],"Testing":[1503],"Infrequently":[1505],"Isolated":[1506],"Fastidious":[1508],"Bacteria:":[1509],"Approved":[1510],"Guideline.":[1511],"M45-A2.":[1514],"2nd":[1515],"ed.":[1516],"2011.":[1520],"34:":[1522],"DOSING:":[1524],"PRACTICAL":[1525],"USE":[1526],"PHARMACODYNAMICS1,2":[1528],"established":[1533],"efficacy":[1536],"beta-lactams":[1538],"MIC,":[1544],"some":[1545],"investigators":[1546],"looked":[1548],"extending":[1550],"infusion,":[1554],"interval":[1556],"between":[1557],"infusions,":[1558],"improve":[1560],"Lodise":[1562,1702],"al3":[1564],"investigated":[1565],"3.375":[1566,1576],"g":[1567,1577,1624,1636],"intravenously":[1568,1578,1637],"30":[1570],"minutes":[1571],"every":[1572,1582,1638],"6":[1573],"versus":[1575],"hours,":[1584],"improved":[1591,1656],"infusion":[1595,1611,1616,1670,1718],"group,":[1596],"significant":[1598,1841],"achieved.":[1602],"looking":[1604],"once-daily":[1607],"home":[1610],"might":[1612],"consider":[1613],"continuous":[1615,1626],"normal":[1620],"renal":[1621],"function,":[1622],"10.125":[1623],"fusion":[1627],"24":[1629],"hours).":[1630],"study":[1632],"investigating":[1633],"cefepime":[1634,1739],"(2":[1635],"infused":[1641,1651],"hours)":[1644],"showed":[1645],"high":[1648,1791],"when":[1650],"long":[1654],"period,":[1655],"likelihood":[1658],"achieving":[1660],"target":[1661],"concentrations":[1662],"aeruginosa":[1665,1711],"ventilator-associated":[1667],"pneumonia.4":[1668],"display":[1675],"superior":[1676],"pharmacokinetics,":[1677],"particularly":[1678],"gram-negative":[1680],"rods.":[1681],"W.":[1685],"34.":[1687,1696],"124a.":[1689],"Rodvold":[1693],"K.":[1694],"124b.":[1698],"IDSA:":[1699],"Lomaestro":[1704],"B,":[1705,1970],"Drusano":[1706],"G.":[1707],"Pipericillin-tazobactam":[1708],"infection:":[1712],"implications":[1714],"dosing":[1719],"strategy.":[1720],"Inf":[1722],"2007;45:357-363.":[1724],"Nicasio":[1726],"AM,":[1727],"Ariano":[1728],"RE,":[1729],"Zelenitsky":[1730],"SA,":[1731],"Population":[1734],"pharmacokinetics":[1735],"high-dosed,":[1737],"prolonged-infusion":[1738],"adult":[1741],"critically":[1742],"ill":[1743],"ventilator":[1746],"associated":[1747],"pneumonia.":[1748],"Antimicrob":[1749],"Agents":[1750],"Chemother.":[1751],"2009;53:1476-1481.":[1752],"ORAL":[1753],"ABSTRACT":[1754],"28:":[1756],"CLOSTRIDIUM":[1757],"DIFFICILE1,2":[1758],"Fidaxomicin":[1759,1875,1973],"class":[1763],"drugs":[1765],"known":[1766],"macrocyclics.":[1768],"narrow":[1772],"activity":[1775],"minimally":[1778],"Bacteroides.":[1781],"little":[1784],"systemic":[1785],"absorption":[1786],"thus,":[1788],"colonic":[1792],"concentration.":[1793],"randomized":[1796,1952],"controlled":[1797,1953],"North":[1800],"America":[1801],"Europe,":[1803],"fidaxomicin":[1804,1868,1903,1942],"studied":[1806],"vancomycin":[1808,1866,1945],"diarrhea.":[1815],"Initial":[1816],"response":[1817],"equivalent":[1819],"both":[1821],"drugs.":[1822],"recurrences":[1826],"vancomycin.":[1828],"Of":[1829],"strains,":[1831],"34%":[1832],"typed":[1834],"B1/NAP":[1836],"difference":[1842],"affects.1":[1845],"follow-up":[1848],"presentation,":[1850],"89":[1856],"submitted":[1858],"serial":[1859],"stool":[1860],"samples,":[1861],"effect":[1864],"intestinal":[1871,1881,1976],"flora":[1872,1882,1913],"measured.":[1874],"killed":[1876],"native":[1880],"vancomycin,":[1884],"although":[1885],"levels":[1886],"expression":[1893,1917],"difficile":[1896,1920,1948,1984],"toxin":[1897,1921,1988],"lower":[1900],"group.":[1904],"authors":[1906],"postulate":[1907],"preserved":[1911],"microbial":[1912],"led":[1914],"thus":[1923],"recurrence":[1925,1991],"disease.":[1927],"Crook":[1930],"D,":[1931],"Miller":[1932],"M,":[1933],"Louie":[1934,1965],"Efficacy":[1938],"safety":[1940],"(FDX)":[1943],"vs":[1944],"1105":[1956],"patients.":[1957],"28,":[1959],"1417.":[1961],"Cannon":[1967],"K,":[1968],"Byrne":[1969],"preserves":[1974],"microbiome":[1977],"reduces":[1987],"re-expression":[1989],"CDI.":[1993]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2321998134","counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}
